Cargando…
Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790740/ https://www.ncbi.nlm.nih.gov/pubmed/33219325 http://dx.doi.org/10.1038/s41436-020-01041-5 |
_version_ | 1783633484487589888 |
---|---|
author | Bichet, Daniel G. Aerts, Johannes M. Auray-Blais, Christiane Maruyama, Hiroki Mehta, Atul B. Skuban, Nina Krusinska, Eva Schiffmann, Raphael |
author_facet | Bichet, Daniel G. Aerts, Johannes M. Auray-Blais, Christiane Maruyama, Hiroki Mehta, Atul B. Skuban, Nina Krusinska, Eva Schiffmann, Raphael |
author_sort | Bichet, Daniel G. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7790740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-77907402021-01-15 Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease Bichet, Daniel G. Aerts, Johannes M. Auray-Blais, Christiane Maruyama, Hiroki Mehta, Atul B. Skuban, Nina Krusinska, Eva Schiffmann, Raphael Genet Med Correction Nature Publishing Group US 2020-11-20 2021 /pmc/articles/PMC7790740/ /pubmed/33219325 http://dx.doi.org/10.1038/s41436-020-01041-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Correction Bichet, Daniel G. Aerts, Johannes M. Auray-Blais, Christiane Maruyama, Hiroki Mehta, Atul B. Skuban, Nina Krusinska, Eva Schiffmann, Raphael Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease |
title | Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease |
title_full | Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease |
title_fullStr | Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease |
title_full_unstemmed | Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease |
title_short | Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease |
title_sort | correction: assessment of plasma lyso-gb(3) for clinical monitoring of treatment response in migalastat-treated patients with fabry disease |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790740/ https://www.ncbi.nlm.nih.gov/pubmed/33219325 http://dx.doi.org/10.1038/s41436-020-01041-5 |
work_keys_str_mv | AT bichetdanielg correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease AT aertsjohannesm correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease AT aurayblaischristiane correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease AT maruyamahiroki correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease AT mehtaatulb correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease AT skubannina correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease AT krusinskaeva correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease AT schiffmannraphael correctionassessmentofplasmalysogb3forclinicalmonitoringoftreatmentresponseinmigalastattreatedpatientswithfabrydisease |